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ABSTRACT
Background and Objectives: Although the adverse cardiovascular effect of anemia has 
been well described, the effect of polycythemia on the incident atrial fibrillation (AF) 
remain unclear. The objective of this study is to identify the association between increased 
hemoglobin and incident AF.
Methods: This was a retrospective-cohort study with 434,269 subjects who underwent 
national health examinations from the Korean National Sample Cohort. We estimated the 
risk of incident AF according to hemoglobin-based four-categories.
Results: During 3.9-year of follow-up, polycythemia group showed higher incidences of AF 
(hazard ratio[HR] with 95% confidence interval[CI], 1.50 [1.28–1.76] and 1.69 [1.13–2.56]; in 
men and women, respectively) than normal hemoglobin group (each p<0.001). In the normal 
hemoglobin and polycythemia groups, a 1 g/dL increase in hemoglobin level was associated 
with increased risks of incident AF (1.12 [1.07–1.17] and 1.18 [1.10–1.26] in men and women, 
each p<0.001). To investigate the specific hemoglobin concentration related to greater AF 
incidence, we analyzed the sensitivity/specificity of different hemoglobin levels: ≥16.0 g/dL 
in men and ≥14.5 g/dL in women showed the highest Youden's index, with c-indices of 0.83 
and 0.82, respectively. Kaplan-Meier cumulative-event curves according to these specific 
hemoglobin levels (≥16.0 g/dL in men and ≥14.5 g/dL in women) also showed consistent 
results in both sexes (each p<0.05).
Conclusions: Even in the Korean general population, increased hemoglobin was significantly 
associated with higher rate of incident AF. Especially, subjects with hemoglobin levels ≥14.5 g/
dL in women and ≥16.0 g/dL among men were associated with increased risk of incident AF.
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INTRODUCTION
Although anemia is a well-known risk factor for poor outcome in patients with cardiovascular 
diseases,1)2) the association between polycythemia and incident atrial fibrillation (AF) has 
not been well studied. A population study showed elevated hematocrit level is associated 
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with an increased risk of adverse cardiovascular events3)4) and adverse cardiovascular 
events include ischemic stroke, and ischemic stroke is highly related to AF. Recent studies 
investigated the relationship between anemia5) or red cell distribution width6) and AF, 
however, there had not been studied about the association between the elevated hematocrit 
and incident AF yet. Recently, we also investigated the clinical impact of elevated hemoglobin 
levels on cardiovascular events after coronary intervention.7) The potential mechanisms of 
polycythemia on cardiovascular outcomes are suggested, such as, the pathophysiologic roles 
of stored iron burden and its hemorheological risks as hemodynamic force. Polycythemia 
increases blood viscosity and can contribute to increasing hemodynamic shear stress8): 
a physical force generated by blood flow that can contribute to pressure overload and 
cardiovascular remodeling.9-11) An experimental study also revealed that cardiac inflammatory 
change under the condition of myocardial ischemia can contribute AF development via 
cardiac remodeling.12) Therefore, elevated hemoglobin level can affect clinical cardiovascular 
event, especially AF development, those had not been well studied yet.
Taken together, there were evidences that hemodynamic forces may affect cardiovascular 
remodeling.11)13) Despite this, the clinical impact of polycythemia and its contribution to AF 
developments have not been well investigated.8)14) In the present study, we conducted a large, 
comprehensive investigation using a Korean cohort covering the general population. The 
primary objective is to identify the association between increased hemoglobin and incident 
AF. The secondary objective is to identify the specific hemoglobin concentration more 
associated with an increased risk for these adverse events. Subgroup analyses were performed 
according to cardiovascular comorbidities to investigate whether high hemoglobin level 
affects the risk of incident AF.
METHODS
This nationwide and retrospective cohort study investigated the relationships between increased 
hemoglobin and incident AF. It was performed according to the recommendations of the 
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement 
reporting guidelines (Supplementary Table 1).15) The study protocol adhered to the ethical 
guidelines of the 2013 Declaration of Helsinki and was approved by the Institutional Review 
Board of Yonsei University College of Medicine (IRB No.3-2019-0322). The need for informed 
consent was waived as the study involved retrospective analysis of an anonymized cohort.
Data source
The present study used the Korean National Health Insurance Service (NHIS)-based National 
Sample Cohort (NSC) database (more than 1 million subjects).16) Because all Korean medical 
facilities were necessarily linked by Korean NHIS, NHIS database includes the information 
of the entire Korean population (more than 50 million subjects). And this sample cohort was 
extracted using probability sampling from all beneficiaries of the National Health Insurance 
and National Medical Aid in 2002 depending on the entire national cohort information. 
Systematic sampling was performed (sampling rate of 2.2% of the whole eligible Korean 
population in 2002 and they were followed until 2015) with respect to each of the 1,476 strata, 
based on age, sex, eligibility status, socioeconomic status, and income level, with the sample 
size proportionate to the cohort size of the strata. A previous study confirmed that the sample 
was representative by comparing it with the entire Korean population.16)
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The cohort database consisted of the three following datasets: i) sociodemographic 
information of the beneficiaries; ii) medical claims, including information on diagnoses 
based on the 10th revision of the International Classification of Disease (ICD-10) codes, 
as well as on records of outpatient visits (including visits to individual physician's office), 
admission, and treatment; iii) National Health Examination data of the cohort members. The 
National Health Examination dataset was created for the entire Korean population from 2002 
to 2015 by the National Health Insurance Corporation. During this time, the National Health 
Examination was conducted biennially and involved chest X-rays, physical examinations, 
detailed questionnaires regarding medical history and lifestyle behaviors (smoking and 
alcohol intake), and regular blood tests including serum creatinine (mL/min) measurements. 
The death registration database of the Korea National Statistical Office, which includes the 
date and cause of death, was linked with the NHIS cohort database. Every subject in the 
sample cohort was linked using Korean social security numbers, all of which were deleted 
after the cohort was constructed and replaced by subject serial numbers to prevent leakage of 
personal information.
Study cohort
Among the entire South Korean population (about 47 million people in 2002), 96.6% 
were registered in the NHIS. About 70% of the entire cohort underwent a National Health 
Examination. Adults over 18 years of age (n=506,805) who had undergone a National 
Health Examination at least once between 2009 and 2015 were included in the NHIS-NSC 
(n=1,041,441) (NHIS-2016-2-189).16) Each of them was then followed from the day of their 
health examination until 31 December 2015. To acquire the enrolled subjects' medical 
history, screening was carried out from January 2002 to December 2008 (disease-free 
baseline period). The subjects' past medical histories were assessed based on the ICD-10 
codes (Supplementary Table 2) to identify diseases such as heart failure, hypertension, 
diabetes mellitus, stroke, myocardial infarction (MI), peripheral vascular disease, or AF 
diagnosed before the health examination. Each diagnosis was defined as the first occurrence 
on at least 2 different days of outpatient hospital visits or on the first hospital admission 
(Supplementary Table 2).16)17) The following exclusion criteria were applied (Figure 1): i) 
those diagnosed with AF (n=4,926, diagnoses based on the ICD-10 codes: ICD-I48) before 
undergoing a health examination; ii) those with valvular AF, such as mitral valve stenosis or 
prosthetic valve disease (n=304, ICD-I050, I052, I342); and iii) missing data (n=67,306) such 
as laboratory data or questionnaires about smoking status and alcohol intake administered at 
the health examinations. Because it had been known that the mechanisms or the causes of AF 
development between valvular and nonvalvular AF were different, we excluded valvular AF as 
the consensus of other previous studies. A final population of 434,269 subjects was included 
in the analysis (Figure 1). In the sensitivity analysis, we additionally excluded those with 
chronic kidney disease (CKD) (with an estimated glomerular filtration rate [eGFR; estimated 
by serum creatinine using CKD-EPI formula18)] lower than 60 mL/min; n=21,115), chronic 
obstructive pulmonary disease (J41–44; n=22,811), cirrhotic liver disease (K74; n=7,123), or 
any malignant disease (C00–C97; n=25,813) because these diseases are related to anemia; 
therefore, they are major confounding factors when analyzing the relationship between 
hemoglobin level and incident AF. After applying these criteria, a population of 366,442 
subjects without chronic diseases related to anemia were included in the sensitivity analysis 
to investigate the robustness of our main analysis. The cohort was followed until the time of 
death; to a condition disqualifying receipt of the NHIS services, such as emigration; or to the 
end of the study (December 31, 2015).
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Lifestyle factors and other clinical variables, and the primary outcome
The subjects' past medical histories were analyzed using medical claims data with ICD codes 
(Supplementary Table 2), questionnaires regarding disease history, and measurements of 
blood pressure and fasting blood glucose levels collected during the health examinations. 
Subjects were classified as obese (body mass index [BMI] ≥27.5 kg/m2), overweight (23.0–27.4 
kg/m2), normal BMI (18.5–22.9 kg/m2), or underweight (<18.5 kg/m2).19) Smoking status was 
classified as non-smoking, <20 pack-years or ≥20 pack-years (former- or current-) smokers. 
Alcohol intake was classified as either 0–220.5 g/week or ≥220.5 g/week. Socioeconomic 
status variable was obtained based on participants' income level, and it was divided into 11 
categories (0–10) and was applied in main analysis.16)
The primary outcome was the relationship between increased hemoglobin level and 
incident AF. To acquire the subjects' stroke history, we investigated cerebral bleeding and 
infarction (ICD-10 code: I60–64), excluding transient ischemic attacks (G45) or other kinds 
of thromboembolisms. The accuracy of the stroke diagnosis in the NHIS database has been 
previously validated.16) 
Statistical analyses
To understand cohort characteristics according to hemoglobin level, we divided the subjects 
according to hemoglobin categories (moderate-to-severe anemia: hemoglobin <11.0 g/
dL for both sexes; mild anemia: ≥11.0 and <13.0 g/dL for men and ≥11.0 and <12.0 g/dL 
for women; normal: ≥13.0 and <16.5 g/dL for men and ≥12.0 and <16.0 g/dL for women; 
and polycythemia groups: hemoglobin ≥16.5 g/dL for men and hemoglobin ≥16.0 g/dL for 
women) based on World Health Organization statement.20) Accordingly, all analyses were 
separately done for both sexes.
1098https://e-kcj.org https://doi.org/10.4070/kcj.2020.0412
Increased Hemoglobin and Incident AF
506,805 who received national
health examinations within 2009–2015
were assessed for eligibility
1,041,441 registered in NHIS-NSC
Subjects over the age of 18 were included 
434,269 who were not diagnosed
with non-valvular atrial fibrillation
(overall general population)
<Exclusion criteria>
• 4,926 who were diagnosed with atrial fibrillation (I48)
before the national health examinations
• 304 who were diagnosed with mitral valve stenosis or
prosthetic valve disease (I050, I052 and I342)
• 67,306 who were excluded owing to missing data*
Mean follow-up duration → 46.2±15.1 months
Figure 1. Study cohort and included subjects from the NHIS-NSC (overall general population). 
NHIS-NSC = National Health Insurance Service-National Sample Cohort. 
*A total of 67,306 were excluded owing to invalid data in health examination items including baseline 
characteristics blood test results, and smoking and alcohol history.
Cox proportional-hazards model regression analyses were used to analyze the association 
between incident AF and polycythemia or anemia, with adjustments for confounding 
variables. Models adjusting for clinical variables (including age, sex, BMI, socioeconomic 
status, hypertension, dyslipidemia, diabetes mellitus history, eGFR, and lifestyle factors such 
as smoking status and alcohol intake) were used to assess these associations. The included 
subjects were followed from their National Health Examination until death, disqualification 
(emigration), or end of the study in the Cox-regression analysis.
To minimize the effects of potential confounders and investigate the robustness of our 
study results, a sensitivity analysis was performed by analyzing subjects without chronic 
diseases related to anemia (see METHODS – Study cohort) to investigate the pure effect of 
hemoglobin on incident AF in this population. Linear estimates of hazard ratios (HRs) about 
relationship between hemoglobin levels and incident AF were tested with adjustment for 
clinical variables. Furthermore, we estimated the predictive accuracy of hemoglobin in case 
of incident AF among subjects with normal hemoglobin levels and those with polycythemia 
by calculating the c-index on the basis of the receiver operating characteristic (ROC) curve 
from logistic regression models. To investigate the specific hemoglobin concentration that 
increased the occurrence of AF, we analyzed the sensitivities and specificities of different 
hemoglobin levels and determined the point with the highest Youden's index (sensitivity + 
specificity − 1).21)22)
A 2-sided p value of <0.05 was considered statistically significant. All statistical analyses 
were performed using R software (version 3.5.2; R Project for Statistical Computing) and SAS 
software (version 9.2, SAS Institute, Cary, NC, USA).
RESULTS
Baseline characteristics
Because the hemoglobin categories were different in both sexes based on World Health 
Organization statement, all analyses were done separately for both sexes. The baseline 
characteristics of men and women according to baseline hemoglobin categories are 
summarized in Table 1. The entire cohort included 217,497 men (851,375 person-years of 
follow-up) and 216,772 women (821,634 person-years of follow-up) who had undergone 
National Health Examinations between 2009 and 2015. The mean hemoglobin levels in 
the moderate-to-severe anemia, mild anemia, normal hemoglobin, and the polycythemia 
groups were 9.7, 12.3, 14.9, and 17.0 g/dL in men and 9.9, 11.5, 13.2, and 16.5 g/dL in women, 
respectively. Among men, subjects with polycythemia (10.0%) were younger, and there 
were more subjects with obesity and heavy alcoholics (≥220.5 g/week) in the polycythemia 
group than in the other groups, while there were fewer subjects with hypertension, diabetes, 
dyslipidemia, chronic lung disease, malignant diseases, and who are taking anti-platelet 
agents, beta-blockers, and statins (each p<0.01) (Table 1). Among women, a small number of 
subjects with polycythemia (0.2%) were older, and more subjects had obesity, hypertension, 
diabetes, dyslipidemia, chronic lung disease, and malignant diseases, and more subjects 
were heavy smokers (≥20 pack-years) and heavy alcoholics (≥220.5 g/week) than in the other 
groups (p<0.01 in all cases) (Table 1).
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Table 1. Baseline characteristics of men (n=217,497) and women (n=216,772) according to Hb levels
Variables
Hb category*
Moderate-to-severe anemia Mild anemia Normal Polycythemia
Men 1,095 8,726 185,978 21,698
Hb (g/dL) 9.7±1.3 12.3±0.5 14.9±0.9 17.0±0.5
Total follow-up (years) 3.3±1.4 3.8±1.3 3.9±1.2 3.8±1.3
Age (years) 62.9±13.8 59.7±14.3 46.5±13.8 42.0±12.2
BMI (kg/m2) 22.3±3.2 22.9±3.1 24.2±3.1 25.3±3.3
Obesity (BMI ≥27.5 kg/m2) 50 (4.6) 628 (7.2) 22,875 (12.3) 4,665 (21.5)
Smoking (pack-years) 13.4±17.9 14.1±17.9 11.6±14.3 12.0±13.5
≥20 pack-years 341 (31.1) 2,906 (33.3) 47,238 (25.4) 5,555 (25.6)
Alcohol intake (g/week) 62.6±142.0 81.6±163.8 106.7±156.5 125.0±163.1
≥220.5 g/week 92 (8.4) 960 (11.0) 26,409 (14.2) 3,797 (17.5)
Socioeconomic status, higher† 641 (58.5) 5,105 (58.5) 115,864 (62.3) 13,583 (62.6)
CHA2DS2-VASc score 2.0±1.8 1.6±1.7 0.6±1.0 0.4±0.8
Heart failure 113 (10.3) 550 (6.3) 3,348 (1.8) 260 (1.2)
Hypertension 592 (54.1) 3,839 (44.0) 37,940 (20.4) 3,363 (15.5)
Diabetes 249 (22.7) 1,571 (18.0) 12,089 (6.5) 1,063 (4.9)
Previous ischemic stroke/TIA 159 (14.5) 916 (10.5) 5,951 (3.2) 477 (2.2)
Previous MI 53 (4.8) 288 (3.3) 2,046 (1.1) 174 (0.8)
Dyslipidemia 402 (36.7) 2,766 (31.7) 32,918 (17.7) 3,320 (15.3)
CKD 325 (29.7) 1,326 (15.2) 9,485 (5.1) 868 (4.0)
Chronic lung disease 74 (6.8) 576 (6.6) 9,299 (5.0) 282 (1.3)
Malignant diseases 280 (25.6) 1,353 (15.5) 11,717 (6.3) 933 (4.3)
Medications at enrollment
Antiplatelet agent 323 (29.5) 2,059 (23.6) 17,482 (9.4) 1,389 (6.4)
Oral anticoagulants 1 (0.1) 14 (0.2) 186 (0.1) 8 (0.0)
Beta-blocker 235 (21.5) 1,353 (15.5) 12,647 (6.8) 1,128 (5.2)
Statin 182 (16.6) 1,291 (14.8) 13,204 (7.1) 1,107 (5.1)
Women 13,476 26,302 176,550 444
Hb (g/dL) 9.9±1.0 11.5±0.3 13.2±0.8 16.5±0.9
Total follow-up (years) 3.7±1.3 3.8±1.2 3.8±1.3 3.7±1.3
Age (years) 48.8±14.9 50.1±15.4 48.6±14.6 53.3±13.5
BMI (kg/m2) 22.7±3.3 22.8±3.2 23.3±3.5 24.9±3.9
Obesity (BMI ≥27.5 kg/m2) 1,075 (8.0) 2,157 (8.2) 19,421 (11.0) 102 (23.0)
Smoking (pack-years) 0.2±1.8 0.3±2.1 0.4±2.6 1.2±5.1
≥20 pack-years 40 (0.3) 79 (0.3) 883 (0.5) 11 (2.4)
Alcohol intake (g/week) 14.1±52.9 14.7±52.6 19.2±58.4 26.5±76.4
≥220.5 g/week 117 (0.9) 239 (0.9) 2,466 (1.4) 14 (3.1)
Socioeconomic status, higher† 7,976 (59.2) 15,402 (58.6) 104,200 (59.0) 238 (53.6)
CHA2DS2-VASc score 1.7±1.4 1.8±1.4 1.6±1.1 2.0±1.4
Heart failure 578 (4.3) 971 (3.7) 4,942 (2.8) 27 (6.0)
Hypertension 2,892 (21.5) 6,449 (24.5) 40,075 (22.7) 173 (39.0)
Diabetes 995 (7.4) 1,823 (6.9) 9,703 (5.5) 54 (12.2)
Previous ischemic stroke/TIA 656 (5.0) 1,370 (5.2) 7,027 (4.0) 30 (6.7)
Previous MI 160 (1.2) 297 (1.1) 1,218 (0.7) 7 (1.5)
Dyslipidemia 2,415 (17.9) 5,705 (21.7) 37,411 (21.2) 147 (33.0)
CKD 1,404 (10.4) 2,233 (8.5) 10,099 (5.7) 49 (11.1)
Chronic lung disease 319 (2.4) 757 (2.9) 4,255 (2.4) 19 (4.4)
Malignant diseases 954 (7.1) 1,964 (7.5) 11,952 (6.8) 43 (9.7)
Medications at enrollment
Antiplatelet agent 1,383 (10.3) 2,971 (11.3) 17,726 (10.0) 75 (16.8)
Oral anticoagulants 5 (0.0) 15 (0.1) 97 (0.1) 1 (0.1)
Beta-blocker 1,070 (8.0) 2,287 (8.7) 14,648 (8.3) 70 (15.8)
Statin 1,048 (7.8) 2,656 (10.1) 17,083 (9.7) 77 (17.3)
Values are expressed as mean±standard deviation or number (%).
BMI = body mass index; CKD = chronic kidney disease; Hb = hemoglobin; MI = myocardial infarction; TIA = transient ischemic attack.
*Baseline Hb levels of included subjects were categorized as followings based on World Health Organization statement (moderate-to-severe anemia: Hb <11.0 
g/dL for both sexes; mild anemia: ≥11.0 and <13.0 g/dL for men and ≥11.0 and <12.0 g/dL for women; normal: ≥13.0 and <16.5 g/dL for men and ≥12.0 and <16.0 g/
dL for women; and polycythemia: Hb ≥16.5 g/dL for men and Hb ≥16.0 g/dL for women).20) †In our cohort, socioeconomic status was divided into 11 categories 
(0–10) and was applied in main analysis. In this table, socioeconomic status was divided into 2 groups: higher (6–10 categories of income level) and lower (0–5 
categories of income level).
Sex-based approach for the associations between increased hemoglobin and 
incident atrial fibrillation
In men, the Cox proportional-hazards models using the covariates of age, BMI, socioeconomic 
status, smoking and alcohol intake habits, baseline creatinine, and histories of hypertension, 
diabetes, and dyslipidemia showed that polycythemia was independently associated with 
increased risks of incident AF (HR with 95% confidence interval [CI], 1.50 [1.28–1.76], p<0.001) 
when compared with normal hemoglobin levels (Table 2). Incident AF events in Table 2 are 
represented as “per 100,000 person-years” to provide more accurate comparisons among 
groups because the follow-up time periods differed among groups. In women, it showed that 
polycythemia was independently associated with increased risks of incident AF (1.69 [1.13–
2.56], p<0.001) when compared with normal hemoglobin levels (Table 2). We performed a 
sensitivity analysis to examine the robustness of our main results in a smaller population after 
the exclusion of patients with chronic diseases affecting hemoglobin levels (see METHODS – 
Study cohort; n=366,442); the overall results were consistent (Supplementary Table 3).
Figure 2 showed the relationships between hemoglobin level and incident AF tested 
using the log-linear model with a thin-plate spline among the overall study population of 
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Table 2. Event rates and corresponding adjusted HRs for incident AF in relation to Hb levels in men and women
Variables
Hb category
Moderate-to-severe anemia Mild anemia Normal (Ref.) Polycythemia
Men 1,095 8,726 185,978 21,698
No. of events 38 193 1,642 190
Age-standardized rate* 394 (191–652) 337 (278–403) 193 (184–203) 302 (275–333)
Adjusted HR (95% CI)† 1.70 (1.27–2.29), p<0.001 1.13 (0.97–1.31), p>0.05 1.00 (Ref.) 1.50 (1.28–1.76), p<0.001
Women 13,476 26,302 176,550 444
No. of events 85 169 1,097 9
Age-standardized rate* 144 (115–178) 141 (121–164) 139 (131–148) 439 (201–833)
Adjusted HR (95% CI)† 1.26 (1.04–1.54), p<0.001 0.97 (0.83–1.13), p>0.05 1.00 (Ref.) 1.69 (1.13–2.56), p<0.001
AF = atrial fibrillation; CI = confidence interval; Hb = hemoglobin; HR = hazard ratio.
*Age-standardized rate: events per 100,000 person-years (age standardization was stratified by 5-year interval). †Age and clinical variables (including body mass 























Figure 2. Concentration-responsive U-shaped relationships between Hb level and incident AF tested by log-linear 
model with a thin-plate spline (age, body mass index, serum creatinine, history of hypertension, diabetes, and 
dyslipidemia, socioeconomic status, and smoking and alcohol intake habits-adjusted HRs). It also showed the 
specific Hb level (lower 95% CI more than 1.0 of HR) associated with increased risk of incident AF in both sexes. 
AF = atrial fibrillation; CI = confidence interval; Hb = hemoglobin; HR = hazard ratio.
434,269 subjects. This test indicated U-shaped associations between hemoglobin level and 
incident AF. The sensitivity analysis among 366,442 subjects also showed consistent results 
(Supplementary Figure 1).
The age-standardized incidence rate of each relevant outcome was also higher in the 
polycythemia group than in the normal hemoglobin group, for both men and women (Table 2).
In both men and women, moderate-to-severe anemia was associated with increased incidences 
of AF (1.70 [1.27–2.29] and 1.26 [1.04–1.54], respectively; p<0.001 in all cases) (Table 2).
Sex-based approach for the associations between hemoglobin and incident 
atrial fibrillation among normal hemoglobin and polycythemia group
We fit the covariate-adjusted Cox proportional-hazards log-linear models with the thin-
plate spline curves for hemoglobin, and the increment in hemoglobin concentration was 
significantly associated with an increased risk of incident AF among subjects with normal 
hemoglobin levels and those with polycythemia. The relationships between hemoglobin level 
and incident AF were almost linear above 14.6 g/dL in women and above 16.1 g/dL in men 
(Figure 2; and Supplementary Figure 1 for the sensitivity analysis). When setting reference 
value as cutoff level of polycythemia, the results also showed consistently in both sexes 
(Supplementary Figure 2). As it had been known increased hematocrit had thromboembolic 
risks, we also analyzed the relationship between increased hemoglobin and incident ischemic 
stroke, and it showed consistent U-shaped relationship (Supplementary Figure 3).
Figure 3A shows the ROC curves for the association between hemoglobin concentration and 
incident AF among women and men. The c-indices of hemoglobin levels concerning these 
associations in the prediction models were 0.82 (0.81–0.83) and 0.83 (0.81–0.84) for women 
and men, respectively. The specific level of hemoglobin associated with an increased risk of 
incident AF was analyzed as above 14.5 g/dL in women and above 16.0 g/dL in men based on 
the highest Youden's index (Figure 3 and Supplementary Table 4; Supplementary Figure 4 
and Supplementary Table 5 for the sensitivity analysis). Figures 3B (women) and 3C (men) 
are Kaplan-Meier cumulative incidence curves according to hemoglobin cutoff (≥14.5 g/dL in 
women and ≥16.0 g/dL in men) among these subjects (all log-rank p<0.05).
Subgroup analysis
Several subgroups among subjects with polycythemia showed association trends about 
an increased risk of incident AF in men and women when compared with the normal 
hemoglobin group: older age subgroup (≥65 years), subjects with heavy smokers (≥20 
pack-years), subjects with lower socioeconomic status, and subjects with diabetes, however, 
interaction p-values compared with the opposite subgroups were all >0.05 in these subgroups 
(Table 3). Meanwhile, hypertensive male subgroup among subjects with polycythemia 
showed higher association trends with an increased risk of incident AF when compared with 
the normal hemoglobin group (1.72 [1.48–2.04] vs. 1.27 [1.07–1.46], p-value for interaction 
was 0.019 compared to the subgroup without history of hypertension) (Table 3).
In the normal hemoglobin and polycythemia groups, a 1 g/dL increase in hemoglobin 
levels was associated with a further increase in the risks of incident AF (1.12 [1.07–1.17] with 
p<0.001 in men; and 1.18 [1.10–1.26] with p<0.001 in women), and most subgroups also 
showed consistent results in both men and women (Table 3).
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In patients with moderate-to-severe anemia, most subgroups among male subjects, and 
elderly, obese, heavy smokers, hypertensive, or diabetes female subjects showed association 
trends about an increased risk of incident AF when compared with the normal hemoglobin 
group, however, most interactions with the opposite subgroups were not significant except 
elderly (aged ≥65 years) male subjects (interaction p<0.001, Table 3).
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Figure 3. (A) ROC curves of specific Hb level for predicting incident AF among normal Hb and polycythemia subjects (among female subjects with Hb ≥13.9 g/dL 
and male subjects with Hb ≥15.2 g/dL who had linearly increasing relationships between Hb and incident AF as they were shown in Figure 2). The c-indices on the 
basis of the AUC for Hb in predicting incident AF were 0.82 and 0.83 in women and men, respectively. Hb levels above 14.5 g/dL in women and above 16.0 g/dL  
in men showed the highest Youden's index (sensitivity + specificity - 1). (B and C) Kaplan-Meier curves (B, women; C, men) about the time-dependent incident AF 
cases according to Hb cutoff (≥14.5 g/dL in women and ≥16.0 g/dL in men) among these subjects (all long-rank p<0.05). 
AF = atrial fibrillation; AUC = area of receiver operating characteristic curve; Hb = hemoglobin; ROC = receiver operating characteristics curve.
DISCUSSION
This nationwide study used a large cohort covering the Korean general population. It 
found that both the polycythemia and anemia groups were associated with increased risks 
of incident AF when compared with the normal hemoglobin group, and that hemoglobin 
levels showed a U-shaped relationship with these conditions. Specifically, above normal 
hemoglobin levels, with 1 g/dL increase in hemoglobin concentration were associated with 
a further increase in the risk of incident AF (by 12.0% in men and by 18.0% in women), even 
after adjusting for clinical variables. We also observed that a hemoglobin level above 14.5 g/dL 
in women and above 16.0 g/dL in men had association trend with an increased risk of 
incident AF.
Although anemia is a well-known risk factor for adverse cardiovascular outcomes,1) the 
association between polycythemia and incident AF had not been well studied. Recent 
observational study revealed the relationship between anemia and AF, however, this study 
did not investigated the association between polycythemia and AF, nor hemoglobin cutoff 
related to an increased risk of AF.5) Another studies have investigated the association 
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Table 3. Subgroup analysis of incident AF and corresponding adjusted HRs in relation to Hb levels in men and women
Variables
Adjusted HR* (95% CI)
According to Hb category With 1 g/dL increase of 
Hb among normal and 
polycythemia group
Moderate-to-severe 
anemia Mild anemia Normal (Ref.) Polycythemia
Men 1.12 (1.07–1.17) ‡p<0.001
Age ≥65 years 3.61 (2.25–5.79)† 1.50 (1.17–1.93) 1.00 (Ref.) 1.52 (1.26–1.83) 1.14 (1.07–1.21) ‡p<0.001
Age <65 years 1.22 (0.84–1.78) 0.99 (0.83–1.18) 1.00 (Ref.) 1.44 (1.07–1.93) 1.10 (1.02–1.17) ‡p=0.010
BMI <18.5 kg/m2 1.26 (0.49–3.26) 0.98 (0.56–1.72) 1.00 (Ref.) 2.08 (1.39–3.49) 1.25 (0.93–1.68)
BMI, 18.5–22.9 kg/m2 0.80 (0.11–5.74) 0.93 (0.73–1.18) 1.00 (Ref.) 1.33 (0.95–1.86) 1.08 (0.99–1.19)
BMI, 23.0–27.4 kg/m2 1.68 (1.03–2.72) 1.18 (0.94–1.48) 1.00 (Ref.) 1.51 (1.05–2.17) 1.12 (1.06–1.20) ‡p<0.001
BMI ≥27.5 kg/m2 1.75 (1.15–2.67) 1.79 (1.17–2.74) 1.00 (Ref.) 1.52 (1.23–1.87) 1.15 (1.03–1.29) ‡p=0.011
Smoking ≥20 pack-years 1.81 (1.09–3.01) 1.22 (1.02–1.46) 1.00 (Ref.) 1.69 (1.34–2.15) 1.12 (1.04–1.20) ‡p=0.003
Non-smoker or smoking <20 pack-years 1.68 (1.17–2.42) 0.98 (0.76–1.27) 1.00 (Ref.) 1.38 (1.12–1.71) 1.12 (1.06–1.19) ‡p<0.001
Lower socioeconomic status 1.72 (1.19–2.47) 1.18 (0.93–1.49) 1.00 (Ref.) 1.61 (1.33–1.94) 1.14 (1.07–1.20) ‡p<0.001
Higher socioeconomic status 1.70 (1.03–2.82) 1.11 (0.92–1.34) 1.00 (Ref.) 1.32 (0.99–1.74) 1.09 (1.01–1.18) ‡p=0.025
Hypertension (+) 1.86 (1.07–3.23) 1.23 (1.03–1.47) 1.00 (Ref.) 1.72 (1.48–2.04)† 1.13 (1.06–1.20) ‡p<0.001
Hypertension (−) 1.67 (1.18–2.37) 0.98 (0.75–1.29) 1.00 (Ref.) 1.27 (1.07–1.46) 1.10 (1.03–1.18) ‡p=0.004
Diabetes (+) 2.20 (1.32–3.66) 1.20 (0.89–1.61) 1.00 (Ref.) 1.50 (1.27–1.78) 1.13 (1.07–1.19) ‡p<0.001
Diabetes (−) 1.58 (1.09–2.28) 1.13 (0.95–1.33) 1.00 (Ref.) 1.49 (0.98–2.32) 1.06 (0.94–1.19)
Women 1.18 (1.10–1.26) ‡p<0.001
Age ≥65 years 1.29 (1.01–1.64) 1.01 (0.78–1.29) 1.00 (Ref.) 3.26 (1.45–7.29) 1.22 (1.10–1.35) ‡p<0.001
Age <65 years 1.25 (0.93–1.80) 0.97 (0.80–1.17) 1.00 (Ref.) 0.42 (0.06–2.98) 1.15 (1.05–1.26) ‡p=0.003
BMI <18.5 kg/m2 1.30 (0.63–2.68) 1.08 (0.85–1.38) 1.00 (Ref.) 4.44 (0.12–14.25) 1.56 (1.07–2.26) ‡p=0.020
BMI, 18.5–22.9 kg/m2 0.95 (0.50–1.80) 0.63 (0.28–1.46) 1.00 (Ref.) 0.87 (0.12–6.20) 1.13 (0.99–1.29)
BMI, 23.0–27.4 kg/m2 1.15 (0.84–1.59) 0.90 (0.71–1.14) 1.00 (Ref.) 1.92 (0.72–5.14) 1.12 (1.02–1.24) ‡p=0.021
BMI ≥27.5 kg/m2 1.39 (1.04–1.86) 1.01 (0.67–1.49) 1.00 (Ref.) 2.69 (0.67–10.81) 1.34 (1.16–1.55) ‡p<0.001
Smoking ≥20 pack–years 1.27 (1.04–1.54) 2.98 (1.02–8.75) 1.00 (Ref.) 1.87 (1.17–3.12) 1.19 (1.11–1.27) ‡p<0.001
Non-smoker or smoking <20 pack-years 1.11 (0.11–11.14) 0.96 (0.82–1.12) 1.00 (Ref.) 1.62 (0.67–3.43) 0.76 (0.42–1.40)
Lower socioeconomic status 1.28 (0.95–1.73) 1.09 (0.90–1.32) 1.00 (Ref.) 2.12 (1.29–3.70) 1.19 (1.09–1.30) ‡p<0.001
Higher socioeconomic status 1.25 (0.97–1.61) 0.82 (0.63–1.05) 1.00 (Ref.) 1.35 (0.43–4.18) 1.17 (1.06–1.30) ‡p=0.003
Hypertension (+) 1.40 (1.11–1.76) 1.02 (0.85–1.23) 1.00 (Ref.) 2.73 (1.08–5.51) 1.19 (1.06–1.34) ‡p=0.003
Hypertension (−) 1.10 (0.77–1.58) 0.90 (0.69–1.18) 1.00 (Ref.) 1.30 (0.49–3.48) 1.17 (1.08–1.27) ‡p<0.001
Diabetes (+) 1.31 (1.05–1.62) 0.99 (0.83–1.17) 1.00 (Ref.) 2.11 (1.01–4.45) 1.18 (1.10–1.27) ‡p<0.001
Diabetes (−) 1.15 (0.75–1.76) 0.93 (0.65–1.33) 1.00 (Ref.) 1.53 (0.41–7.08) 1.17 (1.01–1.38) ‡p=0.049
Bold-faced p values are <0.05 compared to normal Hb group.
AF = atrial fibrillation; BMI = body mass index; CI = confidence interval; Hb = hemoglobin; HR = hazard ratio.
*Age and clinical variables (including BMI, socioeconomic status, smoking and alcohol history, baseline creatinine, and history of hypertension, diabetes, and 
dyslipidemia)–adjusted HR. †Interaction p value <0.05 (compared with the opposite subgroup of each). ‡p<0.05.
between high hemoglobin levels and an increased risk of ischemic cardiovascular outcomes 
or mortalities.23) However, moderate elevations in hematocrit and blood viscosity can also 
be beneficial, because shear stress also induces nitric oxide release.24) Our group recently 
investigated the relationship between anemia and AF recurrence after catheter ablation.25) 
However, these studies did not investigate the relationship between elevated hemoglobin and 
incident AF,5)23)25) or did not investigate either the cutoff value of hemoglobin associated with 
an increased risk of incident AF related to high hemoglobin levels.5)
Interestingly, our data showed that subjects with increased hemoglobin had an increased risk 
of incident AF among men even relatively higher cardiovascular comorbidities compared to 
normal hemoglobin group. The hemorheological risk with hemodynamic force of the stored 
iron burden might be one of the potential mechanisms of increased hemoglobin on incident 
AF. Previous studies showed that increased hematocrit was associated with increased blood 
viscosity and elevated shear stress, it can be possible that increased hemoglobin may also be 
associated with tissue hypoxia or atrial dilation and subsequent AF development.8)26)27) In the 
present study, these associations were observed in several subgroups of men and women, and 
there were higher association trends for incident AF among elderly subjects and subjects with 
hypertension, diabetes, obesity, heavy smokers (≥20 pack-years), and lower socioeconomic 
status in men and similar association trends in women also (Table 3). And hypertensive male 
patients showed more significant association between polycythemia and incident AF compared 
to patients without hypertension (interaction p-value 0.019, Table 3), it might suggest that 
careful observations about cardiovascular events are needed especially in these population.
Several studies have addressed the association between increased hematocrit and elevated 
endothelial shear stress,8)10) or red cell distribution width and AF,6)28) but not much is known 
about the effect of elevated hemoglobin on the incident AF in general Asian populations. 
Recent cohort studies suggested that adverse arrhythmic or neurological outcomes are 
increased, showing a U-shaped relationship between hemoglobin levels and AF,5) and 
dementia.29) A pilot study also suggested that high hematocrit might worsen the degree of 
disability after ischemic stroke.30) Our group previously studied the associations between 
elevated hemoglobin levels and unfavorable outcome after coronary interventions in patients 
with coronary heart diseases.7) However, specific hemoglobin level associated with increased 
risk of incident AF or major ischemic cardiovascular outcomes had not been studied 
well among the general population. In the present study, high levels of hemoglobin were 
associated with increased risks of incident AF in both sexes; especially levels above 14.5 g/
dL in women and above 16.0 g/dL in men. It might suggest that careful observations about 
cardiovascular events are needed especially in these population. Further prospective studies 
are needed to investigate these associations among these populations.
Despite its strengths, our study had some limitations. We included subjects from the 
NHIS-NSC database who had undergone National Health Examinations, thus, there may 
have been selection bias. However, our database was compiled using a stratified sampling 
method based on age, sex, eligibility status, socioeconomic status, and income level, and the 
sample's representativeness was examined previously.16) Furthermore, our analysis adjusted 
for additional available clinical parameters, including BMI, socioeconomic status, and 
smoking and alcohol intake habits.
Generally, there were more subjects with anemia in pre-menopausal younger women 
compared to younger men, therefore, the age discordance between men and women 
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might be resulted from this respect. This study was based on the Administrative claim 
data, we could not obtain the echocardiographic parameters that affect AF development. 
Although we analyzed the effect of hemoglobin on incident AF, with adjustment for 
clinical parameters, there were some confounders regarding the etiologies of anemia and 
polycythemia. We could not evaluate the effect of serum stored iron, hematocrit, and blood 
viscosity because those parameters are absent in NHIS-NSC database. However, it is well 
known that hemoglobin level has relatively linear association with hematocrit or blood 
viscosity. Moreover, the cause of bleeding events and information about transfusion were 
not considered in the present study. Despite this, our overall results were consistent after 
subjects with potential confounders were excluded from the analysis of hemoglobin and 
adverse events (those with chronic diseases such as CKD, chronic obstructive pulmonary 
disease, cirrhotic liver disease, or any malignant diseases). Although the study results of 
female subjects were consistently shown with those of male subjects after adjusting readily 
available cardiovascular comorbidities, the number of female subjects with polycythemia 
was small and they had relatively higher cardiovascular comorbidities, therefore, careful 
interpretation is needed. The conditions of anemia and polycythemia can be influenced by 
taking certain drugs, such as anticoagulants and oral contraceptives. However, our study 
excluded patients with histories of prevalent AF (Figure 1), and there were few patients who 
taking oral anticoagulants (Table 1). Although oral contraceptives can affect hemoglobin 
levels in women, however, we did not investigate these drugs, this is the limitation of 
this study. However, the sensitivity analysis with excluding such chronic diseases which 
can more affect hemoglobin levels than oral contraceptives showed consistently with our 
main analysis. Because we did not investigate the mechanisms of such hemorheological 
effects of polycythemia on incident AF, it was hard to investigate the reason of the gender 
difference of the increased hemoglobin effects on incident AF. It might also be related to 
the hemorheological effects or hemodynamic forces of the stored iron burden. Previous 
studies have addressed whether blood viscosity and the shear stress of increased hematocrit 
are related to endothelial dysfunction,8)10) but we did not investigate whether increased 
hematocrit is associated with endothelial inflammation or plaque formation; thus, the 
mechanism of the relationship between increased hemoglobin and incident AF remains 
unclear. Also, we did not investigate the long-term effect of the red cell distribution width, or 
the effort for lowering blood viscosity such as voluntary blood donation, further prospective 
study is needed about this regard.
In conclusion, even in the Korean general population, not only anemia, but also increased 
hemoglobin were significantly associated with higher rates of incident AF. Especially, subjects 
with hemoglobin levels ≥14.5 g/dL in women and ≥16.0 g/dL among men were associated 
with increased risks of incident AF. Further prospective studies are needed to investigate 
these associations among patients with increased hemoglobin.
SUPPLEMENTARY MATERIALS
Supplementary Table 1
The STROBE statement checklist.1)
Click here to view
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Supplementary Table 2
Definitions of comorbidities and corresponding ICD-10 codes or conditions
Click here to view
Supplementary Table 3
Sensitivity analysis of event rates and corresponding adjusted HRs for incident AF in relation 
to Hb levels in men and women, with smaller populations after the exclusion of patients with 
chronic diseases affecting Hb levels
Click here to view
Supplementary Table 4
Sensitivities and specificities of different cutoff levels of Hb for predicting incident AF in the 
normal Hb and polycythemia groups
Click here to view
Supplementary Table 5
Sensitivity analysis of sensitivities and specificities of different cutoff levels of Hb for 
predicting incident AF in the normal Hb and polycythemia groups, with smaller populations 
after the exclusion of patients with chronic diseases affecting Hb levels
Click here to view
Supplementary References
Click here to view
Supplementary Figure 1
Sensitivity analysis of concentration-responsive U-shaped relationships between Hb level and 
incident AF tested by log-linear model with a thin-plate spline (age, body mass index, serum 
creatinine, history of hypertension, diabetes, and dyslipidemia, socioeconomic status, and 
smoking and alcohol intake habits-adjusted HRs) among subjects with smaller populations 
after the exclusion of patients with chronic diseases affecting Hb levels. It also showed 
the specific Hb level (lower 95% CI more than 1.0 of HR) associated with increased risk of 
incident AF in both sexes.
Click here to view
Supplementary Figure 2
Concentration-responsive U-shaped relationships between Hb level and incident AF tested 
by log-linear model with a thin-plate spline (age, body mass index, serum creatinine, history 
of hypertension, diabetes, and dyslipidemia, socioeconomic status, and smoking and alcohol 
intake habits-adjusted HRs) using reference value as cutoff level of polycythemia in both 
sexes (≥16.5 and ≥16.0 g/dL in men and women, respectively).
Click here to view
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Supplementary Figure 3
Concentration-responsive U-shaped relationships between Hb level and incident ischemic 
stroke tested by log-linear model with a thin-plate spline (age, body mass index, serum 
creatinine, history of hypertension, diabetes, and dyslipidemia, socioeconomic status, and 
smoking and alcohol intake habits-adjusted HRs).
Click here to view
Supplementary Figure 4
Sensitivity analysis. (A) ROC curves of specific Hb level for predicting incident AF among 
normal Hb and polycythemia subjects from the smaller populations after the exclusion of 
patients with chronic diseases affecting Hb levels (among female subjects with Hb ≥14.1 g/
dL and male subjects with Hb ≥15.2 g/dL who had linearly increasing relationships between 
Hb and incident AF as they were shown in Supplementary Figure 1). The c-indices on the 
basis of the AUC for Hb in predicting incident AF were 0.80 and 0.77 in women and men, 
respectively. Hb levels above 14.5 g/dL in women and above 16.0 g/dL in men showed the 
highest Youden's index (sensitivity + specificity − 1). (B and C) Kaplan-Meier curves (B, 
women; C, men) according to Hb cutoff (≥14.5 g/dL in women and ≥16.0 g/dL in men) among 
these subjects (all long-rank p<0.05).
Click here to view
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